1. Homepage
  2. Equities
  3. Italy
  4. Borsa Italiana
  5. Exor N.V.
  6. Summary
    EXO   NL0012059018

EXOR N.V.

(EXO)
  Report
Delayed Borsa Italiana  -  05/18 11:37:42 am EDT
65.64 EUR   -0.88%
05/05Alan SA announced that it has received €183 million in funding from a group of investors
CI
04/22EXOR N : acquires 45% of Lifenet Healthcare
PU
04/22Exor N.V. signed an agreement to acquire a 45% stake in Lifenet S.r.l. from Invin S.R.L.
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Borsa Italiana
05/12/2022 05/13/2022 05/16/2022 05/17/2022 05/18/2022 Date
63.38(c) 65.4(c) 65.02(c) 66.22(c) 65.64 Last
225 807 143 522 101 245 201 910 228 628 Volume
-1.28% +3.19% -0.58% +1.85% -0.88% Change
More quotes
Estimated financial data (e)
Sales 2022 1 295 M 1 364 M 1 364 M
Net income 2022 3 671 M 3 867 M 3 867 M
Net Debt 2022 - - -
P/E ratio 2022 4,32x
Yield 2022 0,71%
Sales 2023 1 310 M 1 380 M 1 380 M
Net income 2023 2 308 M 2 431 M 2 431 M
Net Debt 2023 - - -
P/E ratio 2023 6,85x
Yield 2023 0,79%
Capitalization 15 513 M 16 340 M 16 340 M
Capi. / Sales 2022 12,0x
Capi. / Sales 2023 11,8x
Nbr of Employees 263 284
Free-Float 44,0%
More Financials
Company
Exor N.V. is one of the leading European investment companies. The company specializes in acquiring medium- and long-term shares in companies located in Europe, the United States, China and India. The portfolio is organized around three activity sectors: - automotive industry: Stellantis N.V. (detention of 14.4%; construction of automobiles, utility vehicles, and construction and agricultural vehicles and... 
More about the company
Ratings of Exor N.V.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about EXOR N.V.
05/05Alan SA announced that it has received €183 million in funding from a group of inv..
CI
04/22EXOR N : acquires 45% of Lifenet Healthcare
PU
04/22Exor N.V. signed an agreement to acquire a 45% stake in Lifenet S.r.l. from Invin S.R.L..
CI
04/12EXOR N : Amended Remuneration Policy
PU
04/12EXOR N : Proxy form and voting instructions to Computershare S.p.A.
PU
03/29EXOR N : launches Italy Seeds Program to back the most promising entrepreneurs in the coun..
PU
03/24Exor agrees increased sale price for PartnerRe by 328 million euros
RE
03/24Exor Swung to Profit in 2021
DJ
03/24EXOR N : Board of Directors approves 2021 results
PU
03/24EXOR N.V. : Annual results
CO
03/24Exor N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/16Italy's Exor Raises Stake In Dutch Mobile Network Operator Veon To 5%
MT
03/16Exor increases stake in telecom operator Veon to more than 5%
RE
03/14Exor N.V. acquired 5% of stake in VEON Ltd..
CI
03/08Exor Launches $545 Million Share Buyback Program
MT
More news
News in other languages on EXOR N.V.
05/17IMPRESE : Top Manager Reputation; sul podio Descalzi, Starace e Messina
05/17CRIPTOVALUTE : i big soccorrono le piattaforme (MF)
05/05EXOR : scommette contro i chip (MF)
04/22TOP STORIES ITALIA : Exor, punta sulla salute e rileva il 45% di Lifenet
04/22EXOR : punta sulla salute e rileva il 45% di Lifenet
More news
Analyst Recommendations on EXOR N.V.
More recommendations
Chart EXOR N.V.
Duration : Period :
Exor N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXOR N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 66,22 €
Average target price 93,88 €
Spread / Average Target 41,8%
EPS Revisions
Managers and Directors
John Jacob Philip Elkann Chairman & Chief Executive Officer
Enrico Vellano Chief Financial Officer
Laurence Debroux Independent Non-Executive Director
Marc Jan Bolland Senior Independent Non-Executive Director
Joseph Yong Bum Bae Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EXOR N.V.-16.13%16 340
PACCAR, INC.-3.58%28 955
DAIMLER TRUCK HOLDING AG-10.85%23 142
KOMATSU LTD.15.24%22 725
KUBOTA CORPORATION-10.75%21 185
EPIROC AB (PUBL)-20.42%20 970